Fotios Koumpouras, MD, is an Associate Professor of Medicine (Rheumatology) at Yale School of Medicine, where he serves as Director of the Yale Lupus Program and Director of Education and Training in Rheumatology. His expertise lies in systemic lupus erythematosus (SLE), clinical trials, and rheumatology education. He leads a multidisciplinary team focusing on SLE care, research, and wellness, and has developed innovative programs such as the Yale Rheumatology-Biobank and the rheumatology-dermatology clinic. Dr. Koumpouras is actively involved in major SLE clinical trials, including those evaluating novel biologics and therapeutic targets. Education: BS, University at Albany, 1994 MD, St. George’s University School of Medicine, 2000 Residency, Stony Brook University Hospital, 2003 Chief Residency, Stony Brook University Hospital, 2004 Fellowship, Yale University School of Medicine, 2006 Investigative Fellowship, Yale University, 2007 Research Interests: Dr. Koumpouras focuses on SLE pathogenesis, biomarkers, and clinical trial development. His work includes studies on interferons, cytokines, and novel therapeutic targets such as DNASE1/DNASE1L3 biologics. He collaborates with immunologists and dermatologists to explore cutaneous lupus and stromal niches. Awards: Physician Scientist Development Award (American College of Rheumatology, 2006) Resident of the Year (Stony Brook University, 2003) Patients' Choice 5th Anniversary Award (2015) Clinical Trials: Dr. Koumpouras leads trials evaluating therapies for SLE, including VIBRANT (VIB4920 for Lupus Nephritis) and the Yale Lupus Biorepository. He is part of the Lupus Clinical Investigators Network (LuCIN), accelerating new therapies. Labs/Teams: His team includes collaborations with immunologists (e.g., Akiko Iwasaki) and rheumatology researchers. The Yale Lupus Program integrates clinical care, research, and education.








